COVID-19 and cancer care: what do international guidelines say?

Alfredo Tartarone, Rosa Lerose

Research output: Contribution to journalArticlepeer-review


Cancer patients are at particular risk from COVID-19 since they usually present multiple risk factors for this infection such as older age, immunosuppressed state, comorbidities (e.g., chronic lung disease, diabetes, cardiovascular diseases), need of frequent hospital admissions and visits. Therefore, in the COVID era, oncologists should carefully weigh risks/benefits when planning cancer therapies and follow-up appointments. Recently, several scientific associations developed specific guidelines or recommendations to help physicians in their clinical practice. This review focuses on main available guidelines/recommendations regarding the cancer patient management during the COVID-19 pandemic.

Original languageEnglish
Article number80
JournalMedical Oncology
Issue number9
Publication statusPublished - Sept 1 2020


  • Cancer patients
  • COVID-19
  • Guidelines
  • Pandemic

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Cancer Research


Dive into the research topics of 'COVID-19 and cancer care: what do international guidelines say?'. Together they form a unique fingerprint.

Cite this